OTC - ACTIVE INGREDIENT SECTION
NIACINAMIDE 2%
3-o-ETHYL ASCORBIC ACID 0.15%
whitening
- Manufacturer
- Guangzhou Meiya Cosmetics Co.. Ltd.
- Effective date
- 2024-09-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 00:19:37
Label at a glance#
Productwhitening
Active ingredientNIACINAMIDE, 3-O-ETHYL ASCORBIC ACID
Label structure10 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Function:Contains niacinamide and sodium hyaluronate essence, penetrates the skin, moisturizes the skin, nourishes the base of the skin, closes pores, and moisturizes the skin at the same time, softens the skin, refreshes the skin.
INDICATIONS & USAGE SECTION
HOW TO USE :After cleansing the skin in the morning and evening,
apply an appropriate amount of essence evenly to the face and massage it to absorb.
WARNINGS SECTION
Precautions:
1. This product is for external use only and is not edible;
2. Avoid eye contact, if accidentally into the eyes, please rinse with water immediately;
3. Do not use it if you have dermatitis or skin damage;
4. Depending on the individual's physical condition, before use,It is recommended to have an allergy test behind the ear and stop using it immediately if you feel unwell.
5. Please keep it out of reach of children, Beware of Children's Mis-eating, and children under the age of 3 should not use it.
6.Store in a dry place at room temperature.
OTC - STOP USE SECTION
1. Avoid eye contact, if accidentally into the eyes, please rinse with water immediately;
2. Do not use it if you have dermatitis or skin damage;
3. Depending on the individual's physical condition, before use,It is recommended to have an allergy test behind the ear and stop using it immediately if you feel unwell.
OTC - DO NOT USE SECTION
1. Avoid eye contact, if accidentally into the eyes, please rinse with water immediately;
2. Do not use it if you have dermatitis or skin damage;
3. Depending on the individual's physical condition, before use,It is recommended to have an allergy test behind the ear and stop using it immediately if you feel unwell.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Please keep it out of reach of children, Beware of Children's Mis-eating, and children under the age of 3 should not use it.
OTC - WHEN USING SECTION
1. This product is for external use only and is not edible;
2. Avoid eye contact, if accidentally into the eyes, please rinse with water immediately;
3. Do not use it if you have dermatitis or skin damage;
4. Depending on the individual's physical condition, before use,It is recommended to have an allergy test behind the ear and stop using it immediately if you feel unwell.
5. Please keep it out of reach of children, Beware of Children's Mis-eating, and children under the age of 3 should not use it.
6.Store in a dry place at room temperature.
DOSAGE & ADMINISTRATION SECTION
After cleansing the skin in the morning and evening,
apply an appropriate amount of essence evenly to the face and massage it to absorb.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- whitening
- OJW Brightening serum
- BUTYLENE GLYCOL
- GLYCERIN
- NIACINAMIDE
- WATER
- METHYLPARABEN
- 1,2-HEXANEDIOL
- PHENOXYETHANOL
- PEG/PPG-14/7 DIMETHYL ETHER
- TREHALOSE
- 3-O-ETHYL ASCORBIC ACID
- ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER (60000 MPA.S AT 0.5%)
- XANTHAN GUM
- HYDROXYPROPYL TETRAHYDROPYRANTRIOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84673-003 | 84673-003-03 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4374e57e-057f-efc7-e063-6394a90a7ed8 | 2135bc0f-5b8a-3765-e063-6294a90a555e | 2025-11-13 | Warnings | 2135bc0f-5b8a-3765-e063-6294a90a555e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.